Tizanidine
Discover related
4 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
Show:
| PsychonautWiki | Pharmacology | DrugCentral | DailyMed | ||
|---|---|---|---|---|---|
| Classification | |||||
| Class / category | — | — | — | ||
| Safety | |||||
| Dangerous interactions | — | — | — | ||
| Dose · Oral | |||||
| Threshold | 25 μg | — | — | — | |
| Light | 2–3 μg | — | — | — | |
| Common | 4–5 μg | — | — | — | |
| Strong | 6–8 μg | — | — | — | |
| Heavy | 8 μg+ | — | — | — | |
| Duration | |||||
| Onset | 15–45 minutes | — | — | — | |
| Total | 2–6 hours | — | — | — | |
| Pharmacology | |||||
| Receptor activity | — | — | ADRA2AADRA2BADRA2CADRA1AAlpha-1B adrenergic receptorNISCH | — | |
| Half-life | — | Approximately 2.5 hours. | — | — | |
| Protein binding | — | About 30% bound to plasma proteins. | — | — | |
PsychonautWiki summary
This page has not been fully approved by the PsychonautWiki administrators. It may contain incorrect information, particularly with respect to dosage, duration, subjective effects, toxicity and other risks. It may also not meet PW style and grammar standards.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.